Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
15.10
-0.33 (-2.14%)
May 12, 2026, 4:08 PM HKT

HKG:1681 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12,70713,1396,7713,7803,1933,495
Market Cap Growth
58.68%94.05%79.14%18.38%-8.64%43.27%
Enterprise Value
8,9379,3183,7881,2581,2252,132
Last Close Price
15.1015.647.773.913.033.13
PE Ratio
10.7710.956.994.374.144.82
Forward PE
8.909.816.574.094.183.80
PS Ratio
3.343.462.141.331.211.39
PB Ratio
2.362.441.450.880.820.98
P/TBV Ratio
2.672.771.661.031.001.25
P/FCF Ratio
9.9910.336.514.483.154.54
P/OCF Ratio
9.429.745.854.192.983.92
PEG Ratio
-0.700.700.700.700.70
EV/Sales Ratio
2.352.451.200.440.460.85
EV/EBITDA Ratio
6.606.933.451.271.382.38
EV/EBIT Ratio
6.987.273.651.381.512.63
EV/FCF Ratio
7.027.323.641.491.212.77
Debt / Equity Ratio
0.040.040.060.130.130.21
Debt / EBITDA Ratio
0.170.170.260.570.580.83
Debt / FCF Ratio
0.190.190.270.670.510.97
Net Debt / Equity Ratio
-0.76-0.76-0.82-0.78-0.75-0.62
Net Debt / EBITDA Ratio
-3.06-3.06-3.49-3.42-3.28-2.49
Net Debt / FCF Ratio
-3.23-3.23-3.68-4.01-2.88-2.89
Asset Turnover
0.560.560.520.500.510.49
Inventory Turnover
2.422.422.071.992.122.13
Quick Ratio
2.982.983.092.602.472.06
Current Ratio
3.223.223.322.862.682.25
Return on Equity (ROE)
23.60%23.60%22.07%21.38%21.53%21.64%
Return on Assets (ROA)
11.74%11.74%10.73%9.93%9.66%9.93%
Return on Invested Capital (ROIC)
91.41%108.02%106.82%88.13%67.03%50.16%
Return on Capital Employed (ROCE)
23.10%23.10%21.80%20.60%20.20%22.00%
Earnings Yield
9.44%9.13%14.31%22.87%24.18%20.73%
FCF Yield
10.01%9.68%15.37%22.34%31.73%22.03%
Dividend Yield
5.18%4.67%7.72%11.52%9.90%9.58%
Payout Ratio
46.23%46.23%74.75%41.59%18.67%33.56%
Buyback Yield / Dilution
-2.77%-2.77%-4.12%-0.91%1.58%1.54%
Total Shareholder Return
2.47%1.90%3.60%10.62%11.48%11.12%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.